characterize v
1. describe or portray the character or the qualities or peculiarities of; "You can characterize his behavior as that of an egotist"; "This poem can be characterized as a lament for a dead lover" [syn: qualify, characterise]
2. be characteristic of; "What characterizes a Venetian painting?" [syn: characterise]

Characterize \Char"ac*ter*ize\, v. t. [imp. & p. p. Characterized; p. pr. & vb. n. Characterizing.] [LL. characterizare, Gr. ?: cf. F. charact['e]riser.]
1. To make distinct and recognizable by peculiar marks or traits; to make with distinctive features. European, Asiatic, Chinese, African, and Grecian faces are Characterized. --Arbuthnot.
2. To engrave or imprint. [Obs.] --Sir M. Hale.
3. To indicate the character of; to describe. Under the name of Tamerlane he intended to characterize King William. --Johnson.
4. To be a characteristic of; to make, or express the character of. The softness and effeminacy which characterize the men of rank in most countries. --W. Irving. Syn: To describe; distinguish; mark; designate; style; particularize; entitle.

See more meaning on Characterize...

• Archaeological genetics: It's not all as old as it at first seems
  Genomic analyses suggest that patterns of genetic diversity which indicate population movement may not be as ancient as previously believed, but may be attributable to recent events. This study published in BioMed Central's open access journal Investigative Genetics, based in the Netherlands, is able to genetically characterize geographically separated subpopu Read more on this news related to 'Characterize'
• iShares: Caution Blows in ETF Flows
  In like a lion, out like a lamb. It’s a saying typically used to describe the weather in March. But it could also be used to characterize the trend we saw in global exchange traded product (ETP) flows ... Read more on this news related to 'Characterize'
• Trevi Therapeutics Commences Clinical Study of Nalbuphine ER
  Trevi Therapeutics, Inc. a drug development company focused on developing Nalbuphine ER for chronic pruritus, announced today that it has commenced a Phase 1, open-label study to characterize and compare the pharmacokinetics, safety and tolerability of escalating oral doses of nalbuphine hydrochloride extended release tablets in end-stage renal disease patients on Read more on this news related to 'Characterize'